This educational activity will provide clinicians with insights on the most relevant clinical data for treating wet age-related macular degeneration and diabetic retinopathy/diabetic macular edema.

This educational activity is intended to help clinicians identify patients with thyroid eye disease who require intervention for elevated blood glucose levels prior to treatment for thyroid eye disease with the insulin-like growth factor 1 receptor antagonist teprotumumab.

This educational activity will review the role of the corneal nerve in ocular surface health and disease as a foundation for enabling proper diagnosis and for selecting optimal treatment.

This educational activity presents an overview of dry eye disease/meibomian gland dysfunction pathophysiology and classification, results from clinical trials investigating new and emerging therapies, and case-based discussions in which experts share insights on developing targeted treatment regimens for managing dry eye disease/meibomian gland dysfunction.